Related references
Note: Only part of the references are listed.Growth factors for diabetic foot ulcers: mixed treatment comparison analysis of randomized clinical trials
Kannan Sridharan et al.
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2018)
Experimental study of epidermal growth factor and acidic fibroblast growth factor in the treatment of diabetic foot wounds
Jiasheng Xu et al.
EXPERIMENTAL AND THERAPEUTIC MEDICINE (2018)
Global epidemiology of diabetic foot ulceration: a systematic review and meta-analysis
Pengzi Zhang et al.
ANNALS OF MEDICINE (2017)
Granulocyte-Colony Stimulating Factor (G-CSF) Accelerates Wound Healing in Hemorrhagic Shock Rats by Enhancing Angiogenesis and Attenuating Apoptosis
Hong Huang et al.
MEDICAL SCIENCE MONITOR (2017)
Low-dose erythropoietin promotes wound-healing of ulcers in diabetics: Evidence from a phase-IIa clinical study
C. Chatzikyrkou et al.
DIABETES & METABOLISM (2016)
Efficacy of Topical Recombinant Human Epidermal Growth Factor for Treatment of Diabetic Foot Ulcer: A Systematic Review and Meta-Analysis
Shaowei Yang et al.
INTERNATIONAL JOURNAL OF LOWER EXTREMITY WOUNDS (2016)
Discontinued dermatological drugs in 2014
Christina Phuong et al.
EXPERT OPINION ON INVESTIGATIONAL DRUGS (2015)
Efficacy of topical recombinant human platelet-derived growth factor for treatment of diabetic lower-extremity ulcers: Systematic review and meta-analysis
Xiao-hong Zhao et al.
METABOLISM-CLINICAL AND EXPERIMENTAL (2014)
Efficacy of intralesional recombinant human epidermal growth factor in diabetic foot ulcers in Mexican patients: A randomized double-blinded controlled trial
Ramiro Gomez-Villa et al.
WOUND REPAIR AND REGENERATION (2014)
Phase I trial on the safety of topical rhVEGF on chronic neuropathic diabetic foot ulcers
J.R. Hanft et al.
Journal of Wound Care (2014)
Comparative study of different treatment options of grade Ill and IV diabetic foot ulcers to reduce the incidence of amputations
Sachin Khandelwal et al.
CLINICS AND PRACTICE (2013)
A Matched Cohort Study of the Risk of Cancer in Users of Becaplermin
Najat Ziyadeh et al.
ADVANCES IN SKIN & WOUND CARE (2011)
Efficacy of topical recombinant human platelet derived growth factor on wound healing in patients with chronic diabetic lower limb ulcers
Shyam S. Jaiswal et al.
INDIAN JOURNAL OF SURGERY (2010)
Diabetic Foot Ulcers Treated with Becaplermin and TheraGauze, a Moisture-Controlling Smart Dressing A Randomized, Multicenter, Prospective Analysis
Adam Landsman et al.
JOURNAL OF THE AMERICAN PODIATRIC MEDICAL ASSOCIATION (2010)
Intra-lesional injections of recombinant human epidermal growth factor promote granulation and healing in advanced diabetic foot ulcers: multicenter, randomised, placebo-controlled, double-blind study
Jose I. Fernandez-Montequin et al.
INTERNATIONAL WOUND JOURNAL (2009)
Clinical efficacy of basic fibroblast growth factor (bFGF) for diabetic ulcer
Hiroshi Uchi et al.
EUROPEAN JOURNAL OF DERMATOLOGY (2009)
Which is the better option: recombinant human PDGF-BB 0.01% gel or standard wound care, in diabetic neuropathic large plantar ulcers off-loaded by a customized contact cast?
Anil Bhansali et al.
DIABETES RESEARCH AND CLINICAL PRACTICE (2008)
Could rusalatide acetate be the future drug of choice for diabetic foot ulcers and fracture repair?
Darrell H. Carney et al.
EXPERT OPINION ON PHARMACOTHERAPY (2008)
Comparison of the therapeutic effects recombinant human acidic and basic fibroblast growth factors in wound healing in diabetic patients
Yi Tan et al.
JOURNAL OF HEALTH SCIENCE (2008)
Growth factors and cytokines in wound healing
Stephan Barrientos et al.
WOUND REPAIR AND REGENERATION (2008)
Thrombin peptide Chrysalin((R)) stimulates healing of diabetic foot ulcers in a placebo-controlled phase I/II study
Caroline Fife et al.
WOUND REPAIR AND REGENERATION (2007)
Talactoferrin alfa, a recombinant human lactoferrin promotes healing of diabetic neuropathic ulcers: a phase 1/2 clinical study
Thomas E. Lyons et al.
AMERICAN JOURNAL OF SURGERY (2007)
Human epidermal growth factor enhances healing of diabetic foot ulcers
MW Tsang et al.
DIABETES CARE (2003)
Growth factors in the treatment of diabetic foot ulcers
SP Bennett et al.
BRITISH JOURNAL OF SURGERY (2003)
Evaluation of granulocyte-colony stimulating factor (Filgrastim) in infected diabetic foot ulcers
T Kastenbauer et al.
DIABETOLOGIA (2003)
Nitric oxide enhances experimental wound healing in diabetes
MB Witte et al.
BRITISH JOURNAL OF SURGERY (2002)
Effects of granulocyte-colony stimulating factor in the treatment of diabetic foot infection
A Yönem et al.
DIABETES OBESITY & METABOLISM (2001)
Randomized prospective controlled trial of recombinant granulocyte colony-stimulating factor as adjunctive therapy for limb-threatening diabetic foot infection
F de Lalla et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2001)
Share Paper
